Neutrophil count, lymphocyte count and neutrophil-to-lymphocyte ratio in relation to response to adjunctive dexamethasone treatment in community-acquired pneumonia

The cornerstones of community-acquired pneumonia (CAP) treatment are early diagnosis and timely initiation of appropriate antibiotic treatment [1]. Despite advances in antibiotic treatment, CAP remains a leading cause of morbidity and mortality worldwide [2]. Adjunctive therapies, such as corticosteroids, might improve clinical outcomes.